21569175|t|Blonanserin in the treatment of delirium.
21569175|a|The purpose of the present study was to provide preliminary data on the usefulness and safety of blonanserin for patients with delirium in the intensive care unit (ICU). The charts of 32 consecutive patients with delirium in the ICU were retrospectively reviewed. These patients were treated with blonanserin. A total of 96.6% had reduction in Memorial Delirium Assessment Scale score. The proportion of patients with side-effects was 24.1%. Blonanserin may be effective and safe in the treatment of delirium in the ICU.
21569175	0	11	Blonanserin	Chemical	MESH:C079310
21569175	32	40	delirium	Disease	MESH:D003693
21569175	139	150	blonanserin	Chemical	MESH:C079310
21569175	155	163	patients	Species	9606
21569175	169	177	delirium	Disease	MESH:D003693
21569175	241	249	patients	Species	9606
21569175	255	263	delirium	Disease	MESH:D003693
21569175	312	320	patients	Species	9606
21569175	339	350	blonanserin	Chemical	MESH:C079310
21569175	395	403	Delirium	Disease	MESH:D003693
21569175	446	454	patients	Species	9606
21569175	484	495	Blonanserin	Chemical	MESH:C079310
21569175	542	550	delirium	Disease	MESH:D003693
21569175	Negative_Correlation	MESH:C079310	MESH:D003693

